Demethylation functional enzyme of flavonoid compound as well as coding gene and application of demethylation functional enzyme

Through the SCbaiCYP82D511 protease in Scutellaria baicalensis, the problem of demethylation and hydroxylation of flavonoids was solved, and structural modification and pharmacokinetic optimization were achieved. It has efficient and environmentally friendly catalytic effect.

CN118995656APending Publication Date: 2024-11-22SHANGHAI UNIV OF T C M
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410982999.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-22
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

The prior art has difficulties in the transformation of the C-7 demethylation structure of flavonoid compounds, especially because the structure of the C-6 and C-7 methoxy groups are relatively stable and difficult to be effectively removed.

Method used

Through the SCbaiCYP82D511 protease obtained from Scutellaria baicalensis, the 7-O-demethylation function of flavonoids is realized, combining C-6 hydroxylation and C-8 hydroxylation to catalyze the generation of demethylation products and improve pharmacokinetics feature.

Benefits of technology

The 7-O-demethylation and hydroxylation structure transformation of flavonoids has been achieved, the catalytic efficiency has been improved, and a microbial catalyst with clinical drug application value has been developed, which is energy-saving and environmentally friendly.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118995656A_ABST
    Figure CN118995656A_ABST
Patent Text Reader

Abstract

The invention belongs to the field of synthetic biology, and discloses a demethylation functional enzyme of a flavonoid compound as well as a coding gene and application of the demethylation functional enzyme. The demethylation functional enzyme of the flavonoid compounds catalyzes 7-site demethylation and 6-site hydroxylation of the flavonoid compounds, and other structures and stability of the flavonoid compounds are not affected while hydroxyl structure modification is carried out on the flavonoid compounds. The microbial catalyst is developed through a genetic engineering technology, hydroxylation structure modification is carried out on the flavonoid compound, the catalytic condition is mild, the requirement for catalytic equipment is low, the catalytic efficiency is high, energy is saved, environment friendliness is achieved, cyclic and continuous use can be achieved, and wide application prospects and market value are achieved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of synthetic biology, and specifically relates to a demethylation functional enzyme of flavonoid compounds, a coding gene and an application thereof. Background Art

[0002] Flavonoids refer to a series of compounds formed by two benzene rings (A- and B-rings) with phenolic hydroxyl groups connected to each other through the central three carbon atoms, and their basic mother nucleus is 2-phenylchromone. According to the degree of oxidation of the central three carbon chains, the connection position of the B-ring (2- or 3-position), and whether the three carbon chains are cyclic, the main flavonoids can be divided into 15 types: flavonoids, flavonols, dihydroflavones, dihydroflavonols, isoflavones, dihydroisoflavones, chalcones, dihydrochalcones, aurones, flavanoids, anthocyanidins, biflavonoids, etc. In addition, there are some flavonoids with very complex structures, including alkaloid flavonoids such as ficus and isoflavone.

[0003] In nature, plants will synthesize and accumulate a large amount of flavonoid antitoxins under the action of biotic and abiotic stresses. So far, it has not been confirmed that natural flavonoids exist in animals and humans, but domestic and foreign studies have shown that the intake of such substances will have an important impact on the metabolic process of organisms, and their biological activity varies with the number and substitution position of hydroxyl and methoxy groups in the molecule. Flavonoids modified with 7-O-glucuronic acid, represented by baicalin and wogonin, have shown excellent pharmacological activity in modern pharmacological research. The phenomenon of 7-O-methylation in the biosynthetic pathway is very common. For example, ObCYP82D33 in sweet basil needs the presence of a methoxy group at the C7 position to perform the F6H function to generate a C-6 hydroxylated derivative, and then removes the methyl group at the 7 position under the action of 2-oxoglutarate-dependent dioxygenase (2-ODDs) ObF7ODM1 with 7-O-demethylation function. However, SCbaiCYP82D511 in Scutellaria baicalensis has evolved the ability to directly catalyze C-6 hydroxylation, and the unique 7-O-demethylation function, which directs the metabolic flow towards the synthesis of baicalin and wogonin, resulting in the emergence of a special metabolic profile in Scutellaria baicalensis.

[0004] Flavonoids have a wide range of applications in the fields of medicine and food due to their activities in removing oxygen free radicals, anti-tumor, regulating the cardiovascular system, anti-oxidation, anti-aging, antibacterial and anti-inflammatory, antiviral, analgesic, anti-allergic, and immunomodulatory, and thus have attracted attention. Due to the different substituents and substitution positions, they have different physicochemical properties and pharmacological activities. Therefore, the research on the chemical synthesis and pharmacological activity of flavonoids has always been a hot topic of concern. With the development of science and technology, the application of new methods in the synthesis of flavonoids has been continuously reported, in order to seek more economical, more efficient, environmentally friendly and sustainable applications.

[0005] For example, enzymes with biocatalytic activity are applied in the field of chemical synthesis. Existing disclosed methods for applying enzymes to the synthesis of flavonoid compounds include: CN109321543A discloses oxygen methyltransferase involved in the synthesis of citrus peel flavonoids and its encoding gene and application, which catalyzes the methylation of specific sites in flavonoid compounds. CN113322288A discloses novel flavonoid hydroxylase, microorganisms for synthesizing flavonoid carbon glycoside compounds and their application, which catalyze the hydroxylation of flavonoid compounds at C-2 or C-3' positions. CN113046333A discloses flavonoid-8-hydroxylase and its application in the synthesis of 8-hydroxyflavonoid compounds, which catalyzes the hydroxylation of flavonoid compounds at C8 position. CN115028699A discloses a transcription factor CsHsf24 and its application in promoting the synthesis and regulation of tea flavonoids, verifying that CsHsf24 binds to the promoter of flavonoid-3'5'-hydroxylase, activates the expression of CsF3'5'H1 gene, and then promotes the increase of the content of catechins, flavonols and other substances. CN116042547A discloses a flavonoid 3'-hydroxylase and its application, catalyzing the conversion of dihydrokaempferol into dihydroquercetin. CN116926026A discloses a flavonoid compound hydroxylase and its construction method and application, which can improve the ortho-hydroxylation efficiency of flavonoid compounds. CN115975963A discloses a method and application of synthesizing hydroxylated flavonoid compounds by whole cell catalysis of Escherichia coli P450 enzyme, screening optimized P450 enzyme, and improving the hydroxylation efficiency through reduction partner engineering, enzyme engineering and whole cell catalytic condition optimization.

[0006] Since the number of hydroxyl groups and the presence of ortho-hydroxyl groups have a significant effect on the antioxidant activity of flavonoids and the in vivo metabolism of active ingredients, hydroxylation of flavonoids is of great significance for the development of clinical drugs and the improvement of pharmacokinetic characteristics. Demethylation is one of the important pathways for hydroxylation structural modification, but existing studies on N-demethylation and O-demethylation are mainly related to the biosynthesis of alkaloids. [12-18] , there is little progress in the demethylation of flavonoid components. When chemical synthesis is used to modify the structure of flavonoid compounds, the C-5 methoxy group close to the C-4 carbonyl group is more easily removed, so that the formed C-5 phenolic hydroxyl group forms a hydrogen bond with the carbonyl group to make the overall structure more stable, while the methoxy groups far from the carbonyl end (such as C-6 and C-7) are difficult to remove due to their relatively stable structures. Therefore, there are certain difficulties in the structural modification of the C-7 position of flavonoid substrates, especially demethylation.

[0007] In view of the current difficulties in structural modification of the C-7 position of flavonoids, especially demethylation structural modification, it is necessary to improve the existing technology and discover active substances with unique catalytic ability for demethylation of flavonoids at the 7th position through bioengineering technology to synthesize demethylation products. Summary of the invention

[0008] The present invention aims to provide a demethylation functional enzyme of flavonoid compounds and a coding gene thereof.

[0009] The invention also provides the catalytic application of the flavonoid compound demethylation functional enzyme.

[0010] The technical solution of the present invention is as follows:

[0011] A functional enzyme for demethylating flavonoid compounds, the amino acid sequence of which contains at least one of the sequences:

[0012] a. the amino acid sequence shown in SEQ ID NO.2; or

[0013] b. A sequence having at least 70% homology to the amino acid sequence shown in SEQ ID NO.2, preferably at least 80% homology, further preferably at least 90% homology, further preferably at least 95% homology, and further preferably at least 98% homology.

[0014] As described above, an enzyme having at least 70% homology with the amino acid sequence shown in SEQ ID NO.2, undergoes substitution, and / or deletion, and / or addition of one or more amino acid residues, or substitution, and / or deletion, and / or addition of one or more polypeptide fragments, has the function of catalyzing the demethylation of flavonoid compounds, and improves the enzyme structure and activity, including but not limited to: aggregating high-activity fragments necessary for methylation, removing non-essential fragments for methylation, fusing synergistic enzyme activity fragments, fusing other active fragments, modifying amino acid residues or polypeptide fragments, etc., generating enzyme derivatives or analogs, improving enzyme activity, and / or improving enzyme structure, and / or improving the physicochemical properties of the enzyme, and / or increasing auxiliary enzyme activity, and / or increasing other activities. The other activities or active fragments can be other demethylation activities, or methylation activities, or other types of chemical catalytic activities such as hydroxylation activities used for the reaction of this step and / or other step reactions in addition to the demethylation activity of the present invention, or can also be modification activities or structural change activities, etc.

[0015] As an embodiment of the present invention, a flavonoid demethylation enzyme has an amino acid sequence as shown in SEQ ID NO. 2. The flavonoid demethylation enzyme is derived from Scutellaria baicalensis, and is the SCbaiCYP82D511 protein in Scutellaria baicalensis.

[0016] A gene for a flavonoid demethylation enzyme, encoding an enzyme that has a flavonoid demethylation function, and containing one or more of the following nucleotide sequences:

[0017] a. the nucleotide sequence shown in SEQ ID NO.1; or

[0018] b. a nucleotide sequence complementary to the nucleotide sequence shown in SEQ ID NO.1; or

[0019] c. a nucleotide sequence that overlaps with the nucleotide sequence shown in SEQ ID NO.1 and has the same coding function; or

[0020] d. a nucleotide sequence that hybridizes with the nucleotide sequence shown in SEQ ID NO.1 and has the same coding function; or

[0021] A nucleotide sequence having the same coding function after a, b, c or d has been mutated; or

[0022] A nucleotide sequence that has at least 70% homology with the nucleotide sequence in a, b, c or d and has the same coding function, preferably a nucleotide sequence that has at least 80% homology with the same coding function, further preferably a nucleotide sequence that has at least 90% homology with the same coding function, further preferably a nucleotide sequence that has at least 95% homology with the same coding function, and even more preferably a nucleotide sequence that has at least 98% homology with the same coding function.

[0023] As an embodiment of the present invention, a gene of a flavonoid demethylation enzyme is composed of the nucleotide sequence shown in SEQ ID NO: 1. The gene is derived from Scutellaria baicalensis, and is the SCbaiCYP82D511 gene in Scutellaria baicalensis.

[0024] The gene of the flavonoid demethylation functional enzyme as described above encodes and expresses a protease, or a derivative, or an analogue having a flavonoid demethylation function, maintains the activity of the flavonoid demethylation functional enzyme, and / or improves the enzyme activity, and / or improves the enzyme structure, and / or improves the enzyme physicochemical properties, and / or increases the activity of auxiliary enzymes, and / or adds other activities.

[0025] The gene mutation of the present invention refers to a change in the base pair composition or arrangement order of the gene structure. According to the change of the base, the gene mutation may include base substitution mutation, frameshift mutation, deletion mutation, insertion mutation and other types. Base substitution mutation includes conversion mutation and transversion mutation. Conversion mutation is a purine replaced by another purine or a pyrimidine replaced by another pyrimidine. Transversion mutation is a purine replaced by a pyrimidine or a pyrimidine replaced by a purine. According to the four bases in the DNA molecule, 4 conversion mutations and 8 transversion mutations may occur. Frameshift mutation refers to a mutation in which a series of coding sequences are misplaced after the insertion or loss of a certain site in a gene fragment. Deletion mutation refers to the deletion of a DNA fragment. Insertion mutation refers to the insertion of an external DNA fragment. The gene mutation of the present invention can have one or more of base substitution mutation, frameshift mutation, deletion mutation, and insertion mutation, encoding and expressing an enzyme with a demethylation function of flavonoid compounds.

[0026] The coding or coding expression of the present invention refers to the protein synthesis process under the guidance of genes, including but not limited to replication, reverse transcription, transcription, translation, post-translational processing and the like.

[0027] The flavonoid compounds include but are not limited to flavones, flavonols, dihydroflavones, dihydroflavonols, isoflavones, dihydroisoflavones, chalcones, dihydrochalcones, aurones, flavanoids, anthocyanidins, biflavonoids, etc.; especially 7-O-methylflavanone.

[0028] A nucleic acid construct, encoding and expressing an enzyme with a demethylation function of flavonoid compounds, comprising a gene of a demethylation function enzyme of flavonoid compounds. The nucleic acid construct of the present invention has complete components required for gene expression, including but not limited to a promoter, a gene coding sequence, a terminator, etc. The nucleic acid construct of the present invention may have a single target coding sequence, or may have multiple target coding sequences, and there may also be a connecting sequence between the multiple target coding sequences. The target coding sequence is connected to one or more regulatory sequences, and the regulatory sequences include but are not limited to a promoter sequence, a terminator sequence, an enhancer sequence, etc. The nucleic acid construct of the present invention may express an enzyme with a demethylation function of flavonoid compounds, may also express a protein or polypeptide that has a synergistic or auxiliary effect with the demethylation function enzyme of flavonoid compounds, may also express a protein or polypeptide that has other activities in addition to the demethylation function enzyme of flavonoid compounds, and may also express a protein or polypeptide that has structurally modified or transformed the demethylation function enzyme of flavonoid compounds, with the purpose of improving enzyme expression, regulating enzyme physicochemical properties, improving enzyme activity, improving enzyme catalytic efficacy, etc.

[0029] A vector comprising a gene of a flavonoid demethylation functional enzyme, and / or a nucleic acid construct comprising a flavonoid demethylation functional enzyme gene. The vector of the present invention can be either a cloning vector or an expression vector, encoding and expressing an enzyme having a demethylation function of flavonoids. The vector of the present invention includes but is not limited to a plasmid vector, a phage vector, a viral vector, a non-viral vector, a minicircular DNA, etc., and the plasmid vector includes but is not limited to pUC series, pcDNA series, pET series, pGEX series, pBR series, pSC series, pEGFP series, pESC series, etc., such as pESC-His, pBR322, pSC101, pUC57, pEGFP-N1, pcDNA3.1 (+), pUCm-T, pET-32a, etc., preferably pESC-His. Phage vectors include but are not limited to lambda phage vectors, single-stranded phage vectors, phagemid vectors, cosmid vectors, etc. Viral vectors include, but are not limited to, papovavirus vectors, adenovirus vectors, herpesvirus vectors, poxvirus vectors, RNA virus vectors, bovine papillomavirus vectors, Epstein-Barr virus vectors, retrovirus vectors, and adeno-associated virus vectors (AAV).

[0030] A host cell, comprising a demethylation functional enzyme gene of a flavonoid compound, and / or a nucleic acid construct comprising a demethylation functional enzyme gene of a flavonoid compound, and / or a vector comprising a demethylation functional enzyme gene of a flavonoid compound. The method of introducing a gene or a nucleic acid construct or a vector into a host cell of the present invention includes but is not limited to virus-mediated transformation, microinjection, particle bombardment, gene gun transformation, electroporation or a competent state method, etc., preferably a competent state method, specifically a chemical competent cell. The host cell of the present invention includes but is not limited to prokaryotic cells, eukaryotic cells, animal cells, and insect cells. Prokaryotic cells include but are not limited to Escherichia coli, Bacillus subtilis, Corynebacterium, Streptomyces, lactic acid bacteria, etc., mainly Escherichia coli. Eukaryotic cells are mainly yeast.

[0031] A demethylation functional enzyme for flavonoid compounds is obtained by encoding and expressing a demethylation functional enzyme gene for flavonoid compounds, and / or a nucleic acid construct containing the demethylation functional enzyme gene for flavonoid compounds, and / or a vector containing the demethylation functional enzyme gene for flavonoid compounds, and / or a host cell containing the demethylation functional enzyme gene for flavonoid compounds.

[0032] The demethylation functional enzyme of flavonoid compounds of the present invention, and the gene, nucleic acid construct, vector or host cell capable of encoding and expressing the demethylation functional enzyme of flavonoid compounds can be used to catalyze the methylation and / or hydroxylation reaction of flavonoid compounds. Specifically, catalyze 7-O-demethylation, C-6 hydroxylation and C-8 hydroxylation, and perform hydroxylation structural transformation on flavonoid compounds; and be used to prepare flavonoid compound demethylation catalysts, reagents or materials or components.

[0033] A demethylation catalyst, reagent, material or element of flavonoids, comprising a demethylation enzyme of flavonoids, and / or a demethylation enzyme gene of flavonoids, and / or a nucleic acid construct comprising a demethylation enzyme gene of flavonoids, and / or a vector comprising a demethylation enzyme gene of flavonoids, and / or a host cell comprising a demethylation enzyme gene of flavonoids. The reagent, material or element of the present invention is a catalytic tool for realizing the demethylation function or activity of flavonoids, including but not limited to solutions, fibers, microbeads, panels, chips, pipelines, pathways, etc., which meet the requirements of actual catalytic scenarios and load various structures and shapes of catalytic tools for realizing catalytic demethylation enzymes of flavonoids, and / or demethylation enzyme genes of flavonoids, and / or nucleic acid constructs comprising demethylation enzyme genes of flavonoids, and / or vectors comprising demethylation enzyme genes of flavonoids, and / or host cells comprising demethylation enzyme genes of flavonoids.

[0034] A demethylation method for flavonoid compounds, using flavonoid compounds and / or their derivatives and / or their analogs as substrates, and using the above-mentioned demethylation functional enzymes of flavonoid compounds, genes, nucleic acid constructs, vectors or host cells that can encode and express the demethylation functional enzymes of flavonoid compounds as catalysts. The flavonoid compounds include but are not limited to flavonoids, flavonols, dihydroflavones, dihydroflavonols, isoflavones, dihydroisoflavones, chalcones, dihydrochalcones, aurones, flavanoids, anthocyanidins, biflavonoids, etc.; especially 7-O-methylflavanone.

[0035] The demethylation functional enzyme of the flavonoid compound of the present invention can achieve 7-O-demethylation, and / or perform C-6 hydroxylation, and / or perform C-8 hydroxylation, and 7-O-demethylation can be performed simultaneously with C-6 hydroxylation and C-8 hydroxylation. The derivatives or analogs of the flavonoid compound of the present invention have the same or similar parent core structure as the flavonoid compound, and can also be structurally modified by the demethylation method of the flavonoid compound of the present invention.

[0036] Specifically, as shown in the embodiments of the present invention, 7-O-methyl chrysin, genkwain, 5,7-dimethoxyflavone in 7-O-methyl chrysin is catalyzed to transform 7-O-methyl chrysin into 7-O-demethylated products chrysin and baicalein-7-methyl ether, genkwain is transformed into 7-methoxy baicalein and apigenin, and 5,7-dimethoxyflavone is transformed into 5-O-methyl chrysin. The catalyst has 7-O-demethylation activity and C-6 hydroxylation activity.

[0037] It catalyzes the conversion of 7-O-methyl pinospermone and sakurain in 7-O-methyl flavanone, 7-O-methyl pinospermone into 7-O-demethylated products such as pinospermone, dihydrobaicalin and 7-O-methyldihydrobaicalin, and sakurain into 5,6,4'-trihydroxy-7-methoxyflavanone, 5,8,4'-trihydroxy-7-methoxyflavanone, naringenin, safflower and isocarpentin. It has 7-O-demethylation activity, C-6 hydroxylation activity and C-8 hydroxylation activity. The 7-O-demethylation activity, C-6 hydroxylation activity and C-8 hydroxylation activity can be carried out separately, the 7-O-demethylation activity and C-6 hydroxylation activity can be carried out simultaneously, and the 7-O-demethylation activity and C-6 hydroxylation activity can also be carried out simultaneously.

[0038] The invention obtains a demethylation functional enzyme gene SCbaiCYP82D511 of flavonoid compounds from Scutellaria baicalensis and uses the gene for expressing proteins. The obtained protease has significant catalytic activity, catalyzes 7-O-demethylation and C-6 hydroxylation and C-8 hydroxylation of 7-O-methyl flavonoid compounds and flavanone compounds, realizes the hydroxylation structural transformation of flavonoid compounds, does not affect other structures and stability of flavonoid compounds, does not have adverse effects on flavonoid compounds, and has important significance for developing clinical drugs and improving pharmacokinetics.

[0039] The present invention uses genetic engineering technology to transform the hydroxylation structure of flavonoid compounds and develop microbial catalysts, which have mild catalytic conditions, low requirements for catalytic equipment, high catalytic efficiency, energy saving and environmental protection, and can be recycled and continuously used. It has broad application prospects and market value. BRIEF DESCRIPTION OF THE DRAWINGS

[0040] Figure 1 This study is to study the catalytic function of SCbaiCYP82D511 in Scutellaria baicalensis Georgi using 7-O-methylflavone as substrate.

[0041] Figure 2 This study is to study the catalytic function of SCbaiCYP82D511 in Scutellaria baicalensis using 7-O-methylflavanone as substrate. DETAILED DESCRIPTION

[0042] The present invention will be further described below in conjunction with specific embodiments. It should be understood that these embodiments are only used to illustrate the present invention and are not intended to limit the scope of the present invention. In addition, it should be understood that after reading the content taught by the present invention, those skilled in the art can make various changes or modifications to the present invention, and these equivalent forms fall within the scope limited by the appended claims of the application equally.

[0043] Example 1 Cloning of Scutellaria baicalensis SCbai CYP82D511 gene

[0044] 1.1 Extraction of total RNA from Scutellaria baicalensis

[0045] (1) Add about 100 mg of freshly collected Scutellaria baicalensis plant sample (equal amounts of roots and leaves) to a 1.5 ml RNase-Free EP tube, and add 2-3 small enzyme-inactivating steel beads to the tube (tweezers, scissors and other instruments must be quenched in liquid nitrogen before use).

[0046] (2) The rotor of the ultra-low temperature freezer was placed in liquid nitrogen for precooling, and the instrument parameters were set to -20°C, 3000 r, and 20 s for tissue disruption.

[0047] (3) Add 1 mL of Trizol Up and 0.2 mL of RNA Extraction Agent to each tube, homogenize with a homogenizer, and vortex at room temperature for 5 min.

[0048] (4) Place the sample in a precooled centrifuge and centrifuge at 12,000 rpm at 4°C for 15 min.

[0049] (5) Transfer the colorless aqueous phase to a new RNase-Free EP tube, add an equal volume of anhydrous ethanol, and gently invert to mix.

[0050] (6) Add the obtained mixed solution into a centrifugal column and centrifuge at 12000 rpm for 30 seconds, then discard the effluent.

[0051] (7) Add 500 μL CB9 and centrifuge at 12,000 rpm for 30 s at room temperature. Discard the centrifuge solution and repeat this operation twice.

[0052] (8) Transfer the centrifugal column to the 1.5 ml RNase Free EP tube provided in the kit, add 50 μL RNase Free Water, incubate at room temperature for 1 min, and centrifuge at 12000 rpm for 1 min to elute to obtain the RNA solution.

[0053] (9) NANO was used to measure RNA concentration and the RNA was stored at -80°C.

[0054] Note: The gun tips, sample tubes, steel beads, etc. involved in the experiment are all unopened consumables that come with the kit or have been inactivated by enzyme.

[0055] 1.2 Construction of Scutellaria baicalensis cDNA library

[0056] Using PrimeScript TM RNA reverse transcription was performed using II 1st Strand cDNA Synthesis Kit. The reaction systems are shown in Tables 1 and 2.

[0057] Table 1 Reaction system 1

[0058]

[0059] Note: Incubate in metal bath at 65℃ for 5 min and immediately cool on ice.

[0060] Table 2 Reaction system 2

[0061]

[0062]

[0063] Note: After slowly mixing other ingredients, add enzyme. Incubate at 30℃ for 10min, react at 42℃ for 60min, heat at 95℃ for 5min, and cool on ice immediately. NANO determines cDNA concentration, store at -20℃ for short term, and -80℃ for long term.

[0064] 1.3 Amplification of Scutellaria baicalensis SCbai CYP82D511 gene

[0065] KOD Fx enzyme was used for gene cloning. The preparation of PCR reaction solution was shown in Table 3, and the PCR cycle conditions were shown in Table 4.

[0066] Table 3 Gene cloning reaction system

[0067]

[0068] Note: Add other ingredients first and then add KOD Fx enzyme. Mix the reaction solution thoroughly with a vortexer and then perform PCR. The whole process of adding samples should be performed on ice.

[0069] Table 4 Gene cloning reaction procedure

[0070]

[0071] The SCbaiCYP82D511 cloning primers are as follows.

[0072] SCbaiCYP82D511-F(SEQ ID NO.3):

[0073] aatttttgaaaattcgaattcatggagttgagctctgtcatctatg

[0074] SCbaiCYP82D511-R(SEQ ID NO.4):

[0075] tccatcgatactagtgcggccgcttaatatagagtaggtgacaaccttggagt

[0076] After amplification, the SCbaiCYP82D511 gene sequence was obtained by sequencing.

[0077] SCbaiCYP82D511 gene sequence (SEQ ID NO.1):

[0078]

[0079] SCbaiCYP82D511 protease amino acid sequence (SEQ ID NO.2):

[0080] MELSSVIYGAIALLSLFYCYLHFSKPKKSSLNAPPEAGGARFITGHLHLMDGRSASDKLPHINGLLLADQHGPIFTIRLGVHRAVVVSSWELAKEIFTTHDTAVMARPRLIADDYLSYDGASLGFSPYG PYWREIRKLVTTELLSARRIELQRATRVREITQFTGELYKLWEEKKDGSGRVLVDMKQWLGNLSLNLVSRMVVGKRFYGGDDSETTKRWRGVMREFFQLIGQFIPGDGLPFLRWLDLGGFEKRTRDTAY ELDKIIAMWLAEYRKREYSGDDKEQCFMALMLSLVQANPTLQLHYDADTIIKATCQVLISAASDTTTVILIWVISLLLNNADVLKKVQEELDEQVGRERRVEESDISNLPYLQAVVKETMRLYPPAPFA GVRAFSEDCTVGGYHIQKGTFLIVNLWKLHRDPRVWSDDALEFKPQRFFDKKVEVKGQDFELMPFGGGRRMCPGSNLGMHMVHFVLANILQAFDITTGSTVDMTESVGLLTNMKATPLDAILTPRLSPTLY

[0081] Example 2: Connecting the SCbaiCYP82D511 gene into the pESC-His vector

[0082] (1) The pESC-His vector was double-digested with restriction endonucleases EcoRI-HF and NotI-HF. After reacting at 37°C for 5 h, the gene fragment was recovered and purified by agarose gel.

[0083] (2) After the target gene was recovered and purified on agarose gel, it was homologously recombined with the cut vector using the ClonExpress II OneStep Cloning Kit (Table 5).

[0084] (3) Take 10 μL of the ligation product and add it to 100 μL of thawed Trans1-T1 Phage Resistant chemically competent cells, flick to mix, and place on ice for 30 min.

[0085] (4) After heat shock in a 42°C metal bath for 1.5 min, the cells were immediately placed on ice for 5 min. 1 mL of LB0 medium without resistance was then added and the cells were cultured in a shaker for 1 h (200 rpm, 37°C).

[0086] (5) Centrifuge at 8000 rpm for 2 min, discard the supernatant, and mix the remaining 50 μL solution by pipetting.

[0087] The cells were plated on carbenicillin-resistant LB0 plates and cultured in a 37°C constant temperature incubator overnight (12-16 h).

[0088] (6) Select positive single clones, add 10 μL of sterile water, and repeatedly pipette to mix. Pipette 2 μL into the PCR system (Table 6) as a template and use 2x Taq enzyme to identify positive clones.

[0089] (7) Add 500 μL of anti-antibody culture medium to the EP tube and culture at 37°C and 220 rpm in a shaking incubator.

[0090] (8) After the PCR process is completed, the bands are detected by agarose gel electrophoresis and sent to the company for sequencing. The positive strains are selected and the plasmids are extracted for later use.

[0091] Table 5 Homologous recombination reaction system

[0092]

[0093] Table 6 Positive clone identification reaction system

[0094]

[0095] Example 3 Yeast transformation, screening and induced expression

[0096] 3.1 Preparation of competent yeast cells

[0097] (1) A single clone of WAT11 Saccharomyces cerevisiae was selected and cultured in 5 mL YPDA liquid medium at 200 rpm for several hours. When the OD600 of the bacterial solution was about 0.2-0.3, 1 mL of the bacteria was transferred to 100 mL YPDA liquid medium and cultured at 200 rpm for several hours until the OD600 reached 0.4-0.5.

[0098] (2) The yeast cells were collected by centrifugation at 6000 rpm for 5 min, and the supernatant was removed. The Super Yeast Transformation Kit Plus reagent was used for subsequent experiments.

[0099] (3) Resuspend the cells in 10 mL of Y1 solution and centrifuge at 6000 rpm for 5 min to discard the supernatant.

[0100] (4) Add 1 mL of Y2 solution to resuspend the cells and dispense into 1.5 mL sterile EP tubes at 50 μL / tube for transformation and store at -80°C for long term storage.

[0101] 3.2 Transformation of yeast

[0102] (1) Add 350 μL Y3 solution to a sterile EP tube, add about 200 ng of recombinant plasmid, and use sterile water to make up the system to 360 μL.

[0103] (2) Use a sterile pipette tip to draw up 360 μL of the transformation premix and add it to 50 μL of WAT11 Saccharomyces cerevisiae competent cells. Gently pipette to mix.

[0104] (3) Incubate in a metal bath at 30°C for 60 min, mixing by inverting every 10 min.

[0105] (4) After incubation, centrifuge at 12000 rpm for 1 min, discard the supernatant, and resuspend the cells in 1 mL of sterile water.

[0106] (5) Centrifuge at 12000 rpm for 1 min, remove the supernatant, retain a small amount of liquid, and resuspend the bacteria.

[0107] (6) Use sterile glass beads to spread the bacterial solution on SD-His plates and culture in a constant temperature incubator at 28°C for 2-4 days.

[0108] 3.3 Screening of yeast positive transformants

[0109] (1) Pick up yeast monoclonal cells with a pipette tip and place them in 5 mL SD-His liquid medium. Culture them at 28°C and 200 rpm for 24 h.

[0110] (2) Lyse yeast using Lysis Buffer for Microorganism to Direct PCR as follows:

[0111] ① Take 1 mL of bacterial solution into a sterilized EP tube, centrifuge at 12000 rpm for 1 min, and remove the supernatant.

[0112] ②Take 50 μL of lysis buffer and resuspend the pellet.

[0113] ③ After heat denaturation at 80°C for 15 min in a metal bath, centrifuge at 12000 rpm for 1 min and take 1 μL of the supernatant as a template for bacterial detection reaction.

[0114] (3) Positive clones were identified using rTaq as the enzyme. The PCR system and procedure were the same as those in Table 6.

[0115] (4) Select positive transformants for subsequent experiments and preserve the strains in 20% glycerol.

[0116] 3.4 Yeast expansion and induced expression

[0117] (1) Perform streak test on SD-His solid medium for positive transformants, culture at 30°C for 72 h, pick up yeast monoclonal cells with a pipette tip, and culture at 200 rpm for 24 h in 5 mL of prepared SD-His liquid medium by repeated pipetting and mixing. Then, inoculate 1% of the cells into 125 mL of SD-His liquid medium at 200 rpm for another 24 h.

[0118] (2) Centrifuge at 6000 rpm for 5 min to collect yeast cells, remove the supernatant, and resuspend the cells in 20 mL of sterile water.

[0119] (3) Centrifuge at 6000 rpm for 5 min, collect the yeast cells, remove the supernatant, and resuspend the cells in 20 mL of YPL liquid medium. Repeat this step three times.

[0120] (4) Add the resuspended yeast solution to 250 mL of YPL liquid medium and culture with shaking at 200 rpm and 30°C for 16 h.

[0121] Example 4 Yeast in vitro enzyme activity experiment

[0122] 4.1 Extraction of yeast microsomal proteins

[0123] (1) Use a 50 mL centrifuge tube to collect yeast cells by low-speed centrifugation at 3000 × g for 10 min, remove the supernatant, resuspend the cells in 25 mL TEK buffer (1 / 10 of the induction volume), and let stand at room temperature for 5 min.

[0124] (2) Collect yeast cells by low-speed centrifugation at 3000 × g for 10 min, remove the supernatant, and resuspend the cells in 40 mL of pre-cooled TESB.

[0125] (3) The cells were disrupted three times using a low-temperature ultrahigh-pressure continuous flow cell disruptor (1400 bar), all performed on ice.

[0126] (4) Centrifuge at low temperature and high speed for 30 min at 12000 × g. Transfer the supernatant to a 50 mL centrifuge tube containing 10 mL of pre-cooled PEG4000-NaCl solution and place on ice for 15 min.

[0127] (5) Centrifuge at low temperature and high speed for 30 min at 12,000 × g. Remove the supernatant and absorb as much water as possible with absorbent paper. The light brown precipitate at the bottom of the tube is the microsomal protein.

[0128] (6) Add 1 mL of TEG solution to dissolve the precipitate.

[0129] 4.2 In vitro enzyme function assay

[0130] (1) The microsomal enzymatic reaction system (1 mL) is shown in Table 7. The reaction was oscillated at 50 rpm for 16 h.

[0131] (2) Add 10 μL of high concentration hydrochloric acid to terminate the reaction.

[0132] (3) Add 500 μL of ethyl acetate for extraction, vortex and mix well, and centrifuge at 12,000 rpm for 10 min. Use a pipette to carefully transfer the upper organic phase to a new clean 1.5 mL centrifuge tube, and repeat this step three times.

[0133] (4) After the solvent was evaporated using a rotary evaporator, 200 μL of chromatography-grade methanol was added to each sample for reconstitution and vortexed to mix until the sample was fully dissolved.

[0134] (5) The reaction product was analyzed using LC-MS, and the detection conditions were as follows:

[0135] The ultra-high performance liquid chromatography Waters Acquity UPLC and high-resolution tandem mass spectrometry Xevo G2-XSQTOF system were used, which was equipped with a binary pump, a cryogenic sample chamber, an autosampler and a column chamber. The Acquity UPLC T3-C18 (2.1 mm × 100 mm, 1.8 um) reverse phase column of Waters Company of the United States was used, and an aqueous solution containing 0.1% formic acid (phase A) and an acetonitrile solution containing 0.1% formic acid (phase B) were used as mobile phases to collect data on the roots and leaves of Scutellaria baicalensis. The specific parameters were set as follows: flow rate: 0.4 mL / min; injection volume: 1 μL; column temperature: 40°C; elution program: 2-15% B (0-5 min); 15-30% B (5-22 min); 30-60% (22-25 min); 60-95% B (25-30 min); 95-95% B (30-33 min); 95-2% B (33-35 min); and finally maintaining the 2% B phase to stabilize the system for 3 minutes.

[0136] Waters Xevo G2-XS QTOF high-resolution tandem mass spectrometer (MS E) Data were collected in positive and negative ion modes. The specific information is as follows: ion source: ESI; capillary voltage in positive and negative ion modes was set to 3.0 kV and 2.5 kV, respectively; desolvation gas: nitrogen; cone voltage: 30 V; desolvation temperature: 450 °C; ion temperature: 150 °C; scanning range: m / z 50-1200 Da; scanning time: 0.35 s; collision gas: argon. Collision energy during low energy scanning: 6 eV (negative ion mode), 10 eV (positive ion mode), collision energy during high energy scanning: 15-30 eV (positive ion mode and negative ion mode are consistent). Before data collection, the instrument was calibrated with sodium formate solution (0.5 mM), and mass correction was performed using leucine-enkephalin solution (2 ng / μL) as an external reference. Graphical data were viewed and analyzed using MassLynx v.4.2 workstation (Waters, Milford, MA, USA).

[0137] Table 7 In vitro enzyme activity test reaction system

[0138]

[0139] The test results and analysis are as follows:

[0140] (1) The results of the SCbaiCYP82D511 enzyme function experiment using 7-O-methylflavone as substrate are as follows Figure 1 .

[0141] Figure 1The results of in vitro enzyme activity experiments of CYP82D511 in Scutellaria baicalensis using three flavonoid compounds with 7-O-methyl groups, Tectochrysin, Genkwanin, and 5,7-dimethoxyflavone, as substrates were shown. When Tectochrysin was used as a substrate, 7-O-demethylation product Chrysin (the main product) and C-6 hydroxylation product Baicalein-7-methyl ether (7-O-Methylbaicalein, a byproduct) were simultaneously generated under the catalysis of SCbaiCYP82D511. When Genkwain with C-4′ hydroxyl group was used as substrate, SCbaiCYP82D511 showed opposite catalytic characteristics, with F6H as the main function, and the reaction system simultaneously produced C-6 hydroxylation product 7-O-Methylscutellarein (main product) and 7-O-demethylation product apigenin (byproduct). When 5,7-dimethoxyflavone with methoxy group at 5 position was used as substrate, it showed consistent 7-O-demethylation function and generated a large amount of 5-O-Methylchrysin. The reaction products chrysin, baicalein-7-methyl ether, and apigenin were identified by comparison with standards, and 7-O-methylscutellarin and 5-O-methylchrysin were identified by mass spectrometry fragmentation behavior.

[0142] (2) The results of the SCbaiCYP82D511 enzyme function experiment using 7-O-methylflavanone as substrate are as follows Figure 2 .

[0143] Figure 2The results of the enzyme activity experiment of CYP82D511 in Scutellaria baicalensis using two flavanone compounds with 7-O-methyl groups, pinostrobin and sakuranetin, as substrates were shown. When pinostrobin was used as the substrate, the 7-O-demethylated product pinocembrin was the main product, and it could further achieve C-6 hydroxylation to generate dihydrobaicalein; in addition, the C-6 hydroxylation product of pinostrobin, 7-O-methyldihydrobaicalein, was also generated. When sakurain with C-4' hydroxyl group was used as substrate, C-6 hydroxylation product and C-8 hydroxylation product appeared in the reaction system at the same time, and 7-O-demethylation product (Naringenin, naringenin) could be further hydroxylated to generate C-6 / 8 hydroxylation products Carthamidin and Isocarthamidin. The reaction products bromocriptine, dihydrobaicalin, naringenin and safflower were identified by comparison with standard products, and 7-O-methyldihydrobaicalin, 5,6,4'-trihydroxy-7-methoxyflavanone, 5,8,4'-trihydroxy-7-methoxyflavanone and Isocarthamidin were identified by mass spectrometry fragmentation behavior.

[0144] The results of LC-MS analysis showed that SCbaiCYP82D511 from Scutellaria baicalensis Georgi had a significant 7-O-demethylation function for flavonoids and flavanone compounds with 7-O-methyl groups: Tectochrysin, Genkwanin, 5,7-dimethoxyflavone, Pinostrobin, and Sakuranetin.

[0145] In summary, this study found that SCbaiCYP82D511 has excellent 7-O-demethylation catalytic ability and can be used as a functional enzyme for the demethylation of flavonoid compounds, and can catalyze both flavonoid and flavanone substrates. The unique demethylation function of SCbaiCYP82D511 can be used in the field of synthetic biology to produce 7-O-demethylation products, and has great potential in the development of new catalytic elements for microbial production.

Claims

1. A functional enzyme for demethylation of flavonoid compounds, characterized in that: Its amino acid sequence contains at least one of the following sequences: a. the amino acid sequence shown in SEQ ID NO.3; or b. A sequence having at least 70% homology to the amino acid sequence shown in SEQ ID NO: 2 or SEQ ID NO:

3.

2. A flavonoid demethylation enzyme gene, characterized in that: Its nucleotide sequence contains at least one of the following sequences: a. the nucleotide sequence shown in SEQ ID NO: 1; or b. a nucleotide sequence complementary to the nucleotide sequence shown in SEQ ID NO: 1; or c. a nucleotide sequence that overlaps with the nucleotide sequence shown in SEQ ID NO: 1 and has the same coding function; or d. a nucleotide sequence that hybridizes with the nucleotide sequence shown in SEQ ID NO: 1 and has the same coding function; or A nucleotide sequence having the same coding function after a, b, c or d has been mutated; or A nucleotide sequence that has at least 70% homology with the nucleotide sequence in a, b, c or d and has the same coding function.

3. A nucleic acid construct, characterized in that A demethylation functional enzyme gene comprising the flavonoid compound according to any one of claims 2 to 3.

4. A carrier, characterized in that Contains the demethylation functional enzyme gene of flavonoid compounds as claimed in claim 2, and / or contains a nucleic acid construct as claimed in claim 4.

5. A host cell, characterized in that Contains the demethylation functional enzyme gene of flavonoid compounds as described in claim 2, and / or contains a nucleic acid construct as described in claim 3, and / or contains a vector as described in claim 4.

6. A catalyst, reagent or element for demethylation of flavonoids, characterized in that: Comprising the demethylation functional enzyme of the flavonoid compound according to claim 1, and / or the demethylation functional enzyme gene of the flavonoid compound according to claim 2, and / or a nucleic acid construct according to claim 3, and / or a vector according to claim 4, and / or a host cell according to claim 5.

7. Use of the flavonoid demethylation enzyme according to claim 1, and / or the flavonoid demethylation enzyme gene according to claim 2, and / or the nucleic acid construct according to claim 3, and / or the vector according to claim 4, and / or the host cell according to claim 5 in the demethylation and / or hydroxylation reaction of flavonoids.

8. The use according to claim 7, characterized in that: The demethylation is 7-O-demethylation of the flavonoid compound, and the hydroxylation is C-6 hydroxylation and / or C-8 hydroxylation.

9. The use according to claim 7 or 8, characterized in that: The flavonoid compounds include flavones, flavonols, dihydroflavones, dihydroflavonols, isoflavones, dihydroisoflavones, chalcones, dihydrochalcones, aurones, flavanoids, anthocyanidins, and biflavonoids.

10. A method for demethylating flavonoid compounds, wherein the raw materials include flavonoid compounds and / or their derivatives and / or their analogs, characterized in that: The demethylation functional enzyme of flavonoid compounds described in claim 1, and / or the demethylation functional enzyme gene of flavonoid compounds described in claim 2, and / or a nucleic acid construct described in claim 3, and / or a vector described in claim 4, and / or a host cell described in claim 6 are used as catalysts.